ANA Ferreira Pereira de DE ALMEIDA

Prof. ANA Ferreira Pereira de DE ALMEIDA

Instituto Federal de Eduação Tecnológica
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
CNClariano Pires Oliveira Neto
Clariano Pires Oliveira Neto
RARossana Santiago de Sousa Azulay
Rossana Santiago de Sousa Azulay
AAANA Ferreira Pereira de DE ALMEIDA
ANA Ferreira Pereira de DE ALMEIDA
MTMaria da Glória Rodrigues Tavares
Maria da Glória Rodrigues Tavares
LVLuciana Helena Gama Vaz
Luciana Helena Gama Vaz
DLDebora Cristina Ferreira Lago
Debora Cristina Ferreira Lago
In the COVID-19 pandemic, there was an increase in consultations for precocious puberty. We aim to analyze differences in female puberty before and during the COVID-19 pandemic. A cross-sectional analytical study was designed at the Pediatric Endocrinology Clinic of the University Hospital of the Federal University of Maranhão in São Luis, Brazil. We included 55 girls with precocious puberty, 22 who started puberty during the pandemic and 33 who started puberty before the pandemic. Clinical, anthropometric, laboratory and imaging variables were compared between groups. Statistics were performed to determine if there was a statistical difference between the groups. Girls with puberty during the pandemic had higher Z-scores for weight (1.08 ± 1.29 versus 0.69 ± 0.83; p = 0.04), lower ovarian volume (1.88 ± 0.95 versus 3.15 ± 2.31; p = 0.01), and smaller differences between thelarche noticed by the parents and the diagnosis (6.63 ± 5.21 versus 12.15 ± 9.96; p = 0.02). The association between precocious puberty during the pandemic with higher Z-scores for weight, lower ovarian volume, and a reduction in the time between the perception of pubertal findings by parents and the diagnosis suggests the influence of the pandemic on the normal time of puberty.

7 November 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
JFJoana França
Joana França
RARossana Santiago de Sousa Azulay
Rossana Santiago de Sousa Azulay
Vandilson RodriguesVandilson Rodrigues
Vandilson Rodrigues
SASterffeson Lamare Lucena de Abreu
Sterffeson Lamare Lucena de Abreu
MTMaria da Glória Tavares
Maria da Glória Tavares
AFAdalgisa de Souza Paiva Ferreira
Adalgisa de Souza Paiva Ferreira
Background/Objectives: Approximately 25% of the world’s population and more than 60% of patients with type 2 diabetes (T2D) have metabolic-dysfunction-associated steatotic liver disease (MASLD). The association between these pathologies is an important cause of morbidity and mortality in Brazil and worldwide due to the high frequency of advanced fibrosis and cirrhosis. The objective of this study was to determine the epidemiologic and clinical-laboratory profile of patients with T2D and MASLD treated at an endocrinology reference service in a state in northeastern Brazil, and to investigate the association of liver fibrosis with anthropometric and laboratory measurements. Methods: A cross-sectional study was performed in a specialized outpatient clinic with 240 patients evaluated from July 2022 to February 2024, using a questionnaire, physical examination, laboratory tests, and liver elastography with FibroScan®. Results: Estimates showed that women (adjusted OR = 2.69, 95% CI = 1.35–5.35, p = 0.005), obesity (adjusted OR = 2.23, 95% CI = 1.22–4.07, p = 0.009), high GGT (adjusted OR = 3.78, 95% CI = 2.01–7.14, p < 0. 001), high AST (adjusted OR = 6.07, 95% CI = 2.27–16.2, p < 0.001), and high ALT (adjusted OR = 3.83, 95% CI = 1.80–8.11, p < 0.001) were associated with the risk of liver fibrosis even after adjusted analysis. Conclusions: The study findings suggested that female sex and BMI were associated with an increased risk of liver fibrosis, highlighting the importance of comprehensive evaluation of these patients. In addition, FIB-4 and MAF-5 provided a good estimate of liver fibrosis in our population and may serve as a useful tool in a public health setting with limited resources.

30 June 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RARossana Santiago de Sousa Azulay
Rossana Santiago de Sousa Azulay
DLDebora Cristina Ferreira Lago
Debora Cristina Ferreira Lago
GSGlaucia Abreu Silva Santos
Glaucia Abreu Silva Santos
MTMaria da Glória Tavares
Maria da Glória Tavares
Vandilson RodriguesVandilson Rodrigues
Vandilson Rodrigues
MFManuel dos Santos Faria
Manuel dos Santos Faria
We aimed to evaluate the Health-related quality of life (HRQoL) of Type 1 diabetes mellitus (T1D) patients in an admixed Brazilian population. This is a cross-sectional study with 152 T1D patients. HRQoL information was obtained from two self-completed questionnaires: Short Form-6 dimensions and EuroQol-5 dimensions with visual analog scale. For inference of global ancestry, the panel of 46 autosomal informational insertion/deletion ancestry markers was used. Demographic and socioeconomic data, presence of chronic complications, glycemic control level, and type of treatment were obtained. Patients with good HRQoL were: male, under 18 years old, had health insurance, less than 5 years of diagnosis, practiced physical activity, without hypoglycemia in the last 30 days, absence of retinopathy and nephropathy, a participant in educational activities, used analogous insulin, monitoring blood glucose, observed maximum adherence to treatment and came from the secondary service. Global ancestry and self-reported color/race did not influence HRQoL indexes. Our study is the first to measure HRQoL, global ancestry and recognize the impact of T1D on the lives of patients in the State of Maranhão, Brazil. The results validate the need to provide T1D patients with continuous training on self-management and self-monitoring, aiming for better results in metabolic control and, subsequently, in the prevention of acute and chronic complications, in order to generate positive impacts on the quality of life of this population. We understand that global ancestry in a highly mixed population such as ours did not influence the HRQoL of these patients.

1 January 2025 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
FRFernando Barros Costa Ribeiro
Fernando Barros Costa Ribeiro
AAANA Ferreira Pereira de DE ALMEIDA
ANA Ferreira Pereira de DE ALMEIDA
ACAdriana de Sá Caldas
Adriana de Sá Caldas
GNGilvan Cortês Nascimento
Gilvan Cortês Nascimento
RARossana Santiago de Sousa Azulay
Rossana Santiago de Sousa Azulay
CSCarla Souza Pereira Sobral
Carla Souza Pereira Sobral
Objective: To identify factors potentially associated with radioiodine-refractory disease among patients treated for differentiated thyroid carcinoma at a referral center in Northeastern Brazil. Methods: A total of 554 medical records of patients with differentiated thyroid carcinoma treated between January 2010 and August 2024 were evaluated. Radioiodine-refractory disease tumors were detected in 44 (7.9%) patients. Clinical, laboratory, and radiological data were compared between the radioiodine-refractory disease and non-radioiodine-refractory disease groups to determine factors associated with poor differentiated thyroid carcinoma outcomes. [...] Abstract Objective: To identify factors potentially associated with radioiodine-refractory disease among patients treated for differentiated thyroid carcinoma at a referral center in Northeastern Brazil. Methods: A total of 554 medical records of patients with differentiated thyroid carcinoma treated between January 2010 and August 2024 were evaluated. Radioiodine-refractory disease tumors were detected in 44 (7.9%) patients. Clinical, laboratory, and radiological data were compared between the radioiodine-refractory disease and non-radioiodine-refractory disease groups to determine factors associated with poor differentiated thyroid carcinoma outcomes.

Verified
Journal Article
Open access
PDF file
RARossana Santiago de Sousa Azulay
Rossana Santiago de Sousa Azulay
Vandilson RodriguesVandilson Rodrigues
Vandilson Rodrigues
DLDebora Cristina Ferreira Lago
Debora Cristina Ferreira Lago
AAANA Ferreira Pereira de DE ALMEIDA
ANA Ferreira Pereira de DE ALMEIDA
JFJoana França
Joana França
MFManuel dos Santos Faria
Manuel dos Santos Faria
Type 1 diabetes (T1D) is a chronic disease characterized by the immune-mediated destruction of the pancreatic beta cells responsible for insulin production. The secreted insulin and C-peptide are equimolar. Due to its longer half-life, C-peptide has become a safer means of assessing the pancreatic reserve. C-peptide levels were evaluated in a population of patients with T1D, focusing on the relationship between this variable and other factors. In addition, the influence of C-peptide on metabolic control and microvascular complications was investigated. This cross-sectional study included 95 patients who had been diagnosed with T1D at least five years earlier. These patients were evaluated using a clinical demographic survey, anthropometric data, laboratory tests, and fundoscopy. This study showed that 29.5% of patients had residual insulin secretion, which correlated directly with their age at diagnosis. No statistically significant differences in metabolic control or microvascular complications were observed between the C-peptide level groups. In addition, our results indicate that ancestry does not influence the persistence of residual C-peptide function in our highly mixed population. It is recommended that future research consider incorporating new variables, such as HLA and pancreatic autoimmunity, as factors that may influence residual β-cell function.

21 February 2022 in Genes
Verified
Journal Article
Open access
PDF file
RRRoberta Duailibe Ferreira Reis
Roberta Duailibe Ferreira Reis
RARossana Santiago de Sousa Azulay
Rossana Santiago de Sousa Azulay
MTMaria da Glória Tavares
Maria da Glória Tavares
GNGilvan Cortês Nascimento
Gilvan Cortês Nascimento
SDSabrina da Silva Pereira Damianse
Sabrina da Silva Pereira Damianse
MFManuel dos Santos Faria
Manuel dos Santos Faria
Patients with type 1 diabetes (T1D) have a higher risk of developing cardiovascular disease (CVD), which is a major cause of death in this population. This study investigates early markers of CVD associated with clinical data and autosomal ancestry in T1D patients from an admixed Brazilian population. A cross-sectional study was conducted with 99 T1D patients. The mean age of the study sample was 27.6 years and the mean duration of T1D was 14.4 years. The frequencies of abnormalities of the early markers of CVD were 19.6% in the ankle-brachial index (ABI), 4.1% in the coronary artery calcium score (CACS), and 5% in the carotid Doppler. A significant percentage of agreement was observed for the comparison of the frequency of abnormalities between CACS and carotid Doppler (92.2%, p = 0.041). There was no significant association between the level of autosomal ancestry proportions and early markers of CVD. The ABI was useful in the early identification of CVD in asymptomatic young patients with T1D and with a short duration of disease. Although CACS and carotid Doppler are non-invasive tests, carotid Doppler is more cost-effective, and both have limitations in screening for CVD in young patients with a short duration of T1D. We did not find a statistically significant relationship between autosomal ancestry proportions and early CVD markers in an admixed Brazilian population.